Browse Related Topics For:

ANDA

110
Patents
91
Pharmaceutical
68
Patent Litigation
59
Pharmaceutical Patents
55
Generic Drugs
46
Patent Infringement
39
Prescription Drugs
34
FDA
31
Pharmaceutical Manufacturers
27
Reverse Payment Settlement Agreements
24
Hatch-Waxman
22
FTC
21
FTC v Actavis
21
SCOTUS
18
Biotechnology
14
Infringement
12
Actavis Inc.
11
Mylan Pharmaceuticals
11
Obviousness
11
Teva Pharmaceuticals
10
Watson Pharmaceuticals
9
Antitrust Litigation
9
Pfizer
8
Claim Construction
8
Drug Manufacturers
8
Patent-in-Suit
8
Pay-For-Delay
7
Apotex
6
AstraZeneca
6
Prior Art
5
Actavis
5
Appeals
5
FDCA
5
Merck
5
Popular
5
Sandoz
4
Cephalon
4
Generic
4
Jurisdiction
4
Labeling
4
Motion to Dismiss
4
Sherman Act
3
Allergan Inc
3
Amgen
3
Anti-Competitive
3
Life Sciences
3
Manufacturers
3
Medicare Modernization Act
3
Novartis
3
Par Pharmaceutical
3
Personal Jurisdiction
3
Settlement
3
Written Descriptions
2
Antitrust Investigations
2
Antitrust Provisions
2
Biologics
2
Biosimilars
2
BPCIA
2
Bristol-Myers Squibb
2
Cadence Pharmaceuticals Inc.
2
Certiorari
2
DaimlerChrysler v Bauman
2
Eli Lilly
2
Enablement Inquiries
2
Failure To Warn
2
Forum
2
GlaxoSmithKline
2
Induced Infringement
2
Noninfringement
2
Orange Book
2
Patent Applications
2
Preliminary Injunctions
2
Prometheus
2
Safe Harbors
2
Subject Matter Jurisdiction
2
Takeda Pharmaceuticals
2
Trademarks
2
USPTO
1
Administrative Procedure Act
1
Advertising
1
Allergan v. Barr Laboratories
1
Amazon
1
Ambiguous
1
Arbitration
1
Arbitration Agreements
1
Bausch & Lomb
1
Biopharmaceutical
1
Brand
1
Burden of Proof
1
Certifications
1
Chilcott v Teva
1
Citizen Petitions
1
Claim Preclusion
1
Claims Limitations Period
1
Class Action
1
Clear and Convincing Evidence
1
Combination Products
1
Competition
1
Complex Litigation
1
Contract Drafting
1
Copaxone
1
Copyright
1
Corporate Counsel
1
Counterclaims
1
Crestor
1
DaimlerAG
1
Declaratory Judgments
1
Duty to Deal
1
Exclusivity
1
Exemptions
1
Expert Testimony
1
Expert Witness
1
Federal Jurisdiction
1
Federal Rule 12(b)(6)
1
FENTORA
1
First Amendment
1
Fresenius
1
Genzyme
1
Good Faith
1
Healthcare
1
HHS
1
Hoffman LaRoche
1
Indefiniteness
1
Information Reports
1
Integra
1
Intellectual Property Litigation
1
Inter Partes Reexamination
1
Inter Partes Review Proceedings
1
International Arbitration
1
ITC
1
Judge Stark
1
Lanham Act
1
Lipitor
1
Marketing
1
Medicare
1
Mensing
1
Method-of-Use
1
Minimum Contacts
1
Misbranding
1
New Guidance
1
Noerr-Pennington Doctrine
1
Non-Disclosure Agreement
1
Off-Label Promotion
1
Off-Label Use
1
Orphan Drugs
1
Par/Paddock
1
Patent Trial and Appeal Board
1
Patent-Eligible Subject Matter
1
Patients
1
PLIVA v Mensing
1
Preemption
1
Presumption of Validity
1
Product Hopping
1
Product Labels
1
Proposed Legislation
1
Proposed Regulation
1
Public Meetings
1
Purdue Pharma
1
RanBaxy
1
Real Party in Interest
1
Reissue Patents
1
Remand
1
Research Tools
1
Restrictive Covenants
1
Reversal
1
Reverse Payments
1
Rosuvastatin
1
Royalties
1
Rulemaking Process
1
Sales Contracts
1
Sandoz v Amgen
1
Spectrum v Sandoz
1
Split of Authority
1
Standard of Proof
1
Standards-Essential Patents
1
Subsidiaries
1
Trade Secrets
1
Warner Chilcott
1
Wyeth